TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice

Cell

Volumn 86, Issue 4, 1996, Pages 531-542

  Cui, Wei ^a,b   Fowlis, Deborah J ^a,c   Bryson, Sheila ^a   Duffie, Elizabeth ^a   Ireland, Hazel ^a   Balmain, Allan ^a   Akhurst, Rosemary J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; INTEGRIN; KERATIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BENIGN TUMOR; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; SKIN CARCINOMA; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TRANSGENIC MOUSE; ANIMAL; CARCINOMA; CELL CULTURE; FEMALE; IMMUNOLOGICAL PROCEDURES; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALIA; MUS MUSCULUS;

ANIMALS; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; FEMALE; IMMUNOLOGIC TECHNIQUES; INTEGRINS; KERATINS; MICE; MICE, TRANSGENIC; PAPILLOMA; SKIN NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030598681     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80127-0     Document Type: Article

References (93)

1. Akhurst, R.J., Fee, F., and Balmain, A. (1988). Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis. Nature 331, 363-365.
2. Akhurst, R.J., Lehnert, S.A., Faissner, A.J., and Duffie, E. (1990). TGF β in murine morphogenetic processes: the early embryo and cardiogenesis. Development 108, 645-656.
3. Alexandrow, M.G., and Moses, H.L (1995). Transforming growth factor β and cell cycle regulation. Cancer Res. 55, 1452-1457.
4. Ansari, B., Coates, P.J., Greenstein, B.D., and Hall, P.A. (1993). In situ end-labeling detects DNA strand breaks in apoptosis and other physiological and pathological states. J. Pathol. 170, 1-8.
5. Anzano, M.A., Roberts, A.B., Meyers, C.A., Komoriya, A., Lamb, L.C., Smith, J.M., and Sporn, M.B. (1982). Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. Cancer Res. 42, 4776-4778.
6. Arrick, B.A., Lopez, A.R., Elfman, F., Ebner, R., Damsky, C.H., and Derynck, R. (1992). Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor β1. J. Cell Biol. 118, 715-726.
7. Arteaga, C.L., Coffey, R.J., Jr., Dugger, T.C., McCutchen, C.M., Moses, H.L., and Lyons, R.M. (1990). Growth stimulation of human breast cancer cells with anti-transforming growth factor β antibodies: evidence for negative autocrine regulation by transforming growth factor β. Cell Growth Differ. 1, 367-374.
8. Arteaga, C.L., Carty-Dugger, T., Moses, H.L., Hurd, S.D., and Pietenpol, J.A. (1993a). Transforming growth factor β1 can induce estrogen-independent tumorgenicity of human breast cancer cells in athymic mice. Cell Growth Differ. 4, 193-201.
9. Arteaga, C., Hurd, S.D., Winnier, A.R., Johnson, M.D., Fendly, B.M., and Forbes, J.T. (1993b). Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer activity. J. Clin. Invest. 92, 2569-2576.
10. Battifora, H.B. (1976). Spindle cell carcinoma: ultrastructural evidence of squamous origin and collagen production by tumour cells. Cancer 37, 2275-2282.
11. Bergmann, M., Ackerman, L.V., and Kemler, R.L. (1951). Carcinosarcoma of the lung: review of the literature and report of two cases treated by pneumonectomy. Cancer 4, 919-929.
12. Buchmann, A., Ruggeri, B., Klein-Szanto, A.J.P., and Balmain, A. (1991). Progression of squamous carcinoma cells to spindle carcinoma of the mouse skin is associated with an imbalance of H-ras alleles on chromosome 7. Cancer Res. 51, 4097-4101.
13. Bursch, W., Oberhammer, F., and Schulte-Hermann, R. (1992). Cell death by apoptosis and its protective role against disease. Trends Pharmacol. Sci. 13, 245-251.
14. Bursch, W., Oberhammer, F., Jirtle, R.L., Askari, M., Sedivy, R., Grasl-Kraupp, B., Purchio, A.F., and Schulte-Hermann, R. (1993). Transforming growth factor-β1 as asignal for induction of cell death by apoptosis. Br. J. Cancer 67, 531-536.
15. Cano, A., Gamalla, C., Kemp, C.J., Benito, N., Palacios, J., Quintanilla, M., and Balmain, A. (1996). The expression of the cell adhesion molecules E-cadherin, P-cadherin and α6β4 integrin is altered in premalignant skin tumours of p53-deficient mice. Int. J. Cancer 65, 254-262.
16. Caulin, C., Scholl, S.G., Frontelo, P., Gamallo, C., and Quintanilla, M. (1995). Chronic exposure of cultured transfected mouse epidermal cells to TGFβ1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype. Cell Growth Differ. 6, 1027-1035.
17. Chakrabarty, S. (1992). Regulation of human colon-carcinoma cell adhesion to extracellular matrix by transforming growth factor β1. Int. J. Cancer 50, 968-973.
18. Chang, H.L., Gillett, N., Figaro, I., Lopez, A.R., Palladino, M.A., and Derynck, R. (1993). Increased transforming growth factor β expression inhibits cell proliferation in vitro yet increases tumorigenicity and tumor growth of Meth A sarcoma cells. Cancer Res. 53, 4391-4398.
19. Chen, R.-H, Ebner, R., and Derynck, R. (1993). Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 260, 1335-1338.
20. Cheng, C., Tennenbaum, T., Dempsey, P.J., Coffey, R.J., Yuspa, S.H., and Dlugosz, A.A. (1993). Epidermal growth factor receptor ligands regulate keratin 8 expression in keratinocytes, and transforming growth factor α mediates the induction of keratin 8 by the v-ras-Ha oncogene. Cell Growth Differ. 4, 317-327.
21. Cui, W., and Akhurst, R.J. (1996). Transforming growth factors β: biochemistry and biology in vitro and in vivo. In Growth Factors and Cytokines in Health and Disease, C. Bondy and D. LeRoith, eds. (Greenwich, Connecticut: JAI Press), in press.
22. Cui, W., Kemp, C.J., Duffie, E., Balmain, A., and Akhurst, R.J. (1994). Lack of TGFβ1 expression in benign skin tumours of p53 null mice is prognostic for a high risk of malignant conversion. Cancer Res. 54, 5831-5836.
23. Cui, W., Fowlis, D.J., Cousins, F.M., Duffie, E., Bryson, S., Balmain, A., and Akhurst, R.J. (1995). Concerted action of TGFβ1 and its type II receptor in control of epidermal homeostasis in transgenic mice. Genes Dev. 9, 945-955.
24. Derynck, R., Goeddel, D.V., Ullrich, A., Gutterman, J.U., Williams, R.D., Bringman, T.S., and Berger, W.H. (1987). Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res. 47, 707-712.
25. Dickson, R.B., Kasid, A., Huff, K.K., Bates, S.E., Knabbe, C., Bronzert, D., Gelmann, E.P., and Lippman, M.E. (1987). Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 β-estradiol or v-Ha-ras oncogene. Proc. Natl. Acad. Sci. USA 84, 837-841.
26. Dixon, M.J., Garner, J., and Ferguson, M.W. (1991). Immunolocalisation of epidermal growth factor (EGF), EGF receptor and transforming growth factor α (TGFα) during mouse palatogenesis in vitro and in vivo. Anat. Embryol. 184, 83-91.
27. Dlugosz, A.A., Cheng, C., William, E.K., Darwiche, N., Dempsey, P.J., Mann, B., Dunn, A.R., Coffey, R.J., and Yuspa, S.H. (1995). Autocrine transforming growth factor α is dispensible for v-ras-Ha-induced epidermal neoplasia: potential involvement of alternative EGF receptor ligands. Cancer Res. 55, 1883-1893.
28. Evans, H.L., and Smith, J.L. (1980). Spindle cell squamous carcinoma and carcinoma-like tumours of the skin: a comparative study of 38 cases. Cancer 45, 2687-2697.
29. Falcioni, R., Cimino, L., Gentileschi, M.P., D'Agnano, I., Zupi, G., Kennel, S.J., and Sacchi, A. (1994). Expression of β1, β3, β4 and β5 integrins by human lung carcinoma cells of different histotypes. Exp. Cell Res. 210, 113-122.
30. Fitzpatrick, D.R., Denhez, F., Kondaiah, P., and Akhurst, R.J. (1990). Differential expression of TGF β isoforms in murine palatogenesis. Development 109, 585-595.
31. Flanders, K.C., Thompson, N.L., Cissel, D.S., Van Obberghen-Schilling, E., Baker, C.C., Kass, M.E., Ellingsworth, L.R., Roberts, A.B., and Sporn, M.B. (1989). Transforming growth factor-β1 : histochemical localization with antibodies to different epitopes. J. Cell Biol. 108, 653-660.
32. Fowlis, D.J., Flanders, K., Duffie, E., Balmain, A., and Akhurst, R.J. (1992). Discordant TGFβ1 RNA and protein localisations during chemical carcinogenesis of the skin. Cell Growth Differ. 3, 81-91.
33. Fowlis, D.J., Cui, W., Johnson, S.A., Balmain, A., and Akhurst, R.J. (1996). Altered epidermal growth control in vivo in transgenic mice expressing TGFβ1 from an inducible keratin gene promoter. Cell Growth Differ. 7, 679-687.
34. Furstenberger, G., Rogers, M., Schnapke, R., Bauer, G., Hofler, P., and Marks, F. (1989). Stimulatory role of transforming growth factors in multistage skin carcinogenesis: possible explanation for the tumor-inducing effect of wounding in initiated NMRI mouse skin. Int J. Cancer 43, 915-921.
35. Garrigue-Antar, L., Munoz-Antonia, T., Antonia, S.J., Gesmonde, J., Vellucci, V.F., and Reiss, M. (1995). Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res. 55, 3982-3987.
36. Glick, A.B., Kulkarni, A.B., Tennenbaum, T., Hennings, H., Flanders, K.C., O'Reilly, M., Sporn, M.B., Karlsson, S., and Yuspa, S.H. (1993). Loss of expression of transforming growth factor β in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc. Natl. Acad. Sci. USA 90, 6076-6080.
37. Glick, A.B., Lee, M.M., Darwiche, N., Kulkarni, A.B., Karlsson, S., and Yuspa, S.H. (1994). Targeted deletion of the TGF-β1 gene causes rapid progression to squamous cell carcinoma. Genes Dev. 8, 2429-2440.
38. Gomella, L.G., Sargent, E.R., Wade, T.P., Anglard, P., Linehan, W.M., and Kasid, A. (1989). Expression of transforming growth factor α in normal adult kidney and enhanced expression of transforming growth factors α and β in renal cell carcinoma. Cancer Res. 49, 6972-6975.
39. Gomez, M., Navarro, P., Quintanilla, M., and Cano, A. (1992). Expression of α6β4 integrin increases during malignant conversion of mouse epidermal keratinocytes: association of β4 subunit to the cytokeratin subfraction. Exp. Cell Res. 201, 250-261.
40. Gorsch, S.M., Memoli, V.A., Stukel, T.A., Gold, L.I., and Arrick, B.A. (1992). Immunohistochemical staining for transforming growth factor β1 associates with disease progression in human breast cancer. Cancer Res. 52, 6949-6952.
41. Haddow, S., Fowlis, D.J., Parkinson, K., Akhurst, R.J., and Balmain, A. (1991). Loss of growth control by TGFβ occurs at a late stage of mouse carcinogenesis and is independent of ras gene activation. Oncogene 6, 1465-1470.
42. Heino, J., and Massague, J. (1989). Transforming growth factor-β switches the pattern of integrins expressed in MG-63 human osteosarcoma cells and causes a selective loss of cell adhesion to laminin. J. Biol. Chem. 36, 21806-21811.
43. Hennings, H., Spangler, E.F., Shores, R., Mitchell, P., Devor, D., Shamsuddin, A.K.M., Elgjo, K.M., and Yuspa, S.H. (1985). Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis 6, 1607-1610.
44. Hynes, R.O., Marcantonio, E.E., Stepp, M.A., Urry, L.A., and Yee, G.H. (1989). Integrin heterodimer and receptor complexity in avian and mammalian cells. J. Cell Biol. 109, 409-420.
45. Jirtle, R.L., Haag, J.D., Ariazi, E.A., and Gould, M.N. (1993). Increased mannose 6-phosphate/insulin-like growth factor II receptor and transforming growth factor β1 levels during monoterpene-induced regression of mammary tumors. Cancer Res. 53, 3849-3852.
46. Jouanneau, J., Gavrilovic, J., Caruelle, D., Jaye, M., Moens, G., Caruelle, J.P., and Thiery, J.P. (1991a). Secreted or non-secreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility and invasive potential. Proc. Natl. Acad. Sci. USA 88, 2893-2897.
47. Jouanneau, J., Tucker, G.C., Boyer, B., Valles, A.M., and Thierry, J.P. (1991b). Epithelial cell plasticity in neoplasia. Bioessays 3, 525-529.
48. Kaartinen, V., Voncken, J.W., Shuler, C., Warburton, D., Bu, D., Heisterkamp, N., and Groffen, J. (1995). Abnormal lung development and cleft palate in mice lacking TGF-β3 indicates defects of epithelial-mesenchymal interaction. Nature Genet. 11, 415-421.
49. Kemp, C.J., Burns, P.A., Brown, K., Nagase, H., and Balmain, A. (1994). Transgenic approaches to the analysis of ras and p53 function in multistage carcinogenesis. Cold Spring Harbor Symp. Quant. Biol. 59, 427-434.
50. Kimelman, D., and Kirschner, M. (1987). Synergistic induction of mesoderm by FGF and TGF-β and the identification of an mRNA coding for FGF in the early Xenopus embryo. Cell 51, 869-877.
51. Klein-Szanto, A.J., Larcher, F., Bonfil, R.D., and Conti, C.J. (1989). Multistage chemical carcinogenesis protocols produce spindle cell carcinomas of the mouse skin. Carcinogenesis 10, 2169-2172.
52. Krieg, P., Schnapke, R., Furstenberger, G., Vogt, I., and Marks, F. (1991). TGFβ1 and skin carcinogenesis: antiproliferative effect in vitro and TGFβ1 mRNA during epidermal hyperproliferation and multistage tumorigenesis. Mol. Carcinog. 4, 129-137.
53. Lenventon, G.S., and Evans, H.L. (1981). Sarcomatoid squamous cell carcinoma of the mucous membranes of the head and neck: a clinicopathologic study of 20 cases. Cancer 48, 994-1003.
54. Lin, J., and Chou, C. (1992). In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor β1. Cancer Res. 52, 385-388.
55. Manning, A.M., Williams, A.C., Games, S.M., and Paraskeva, C. (1991). Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor β (TGF-β): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-β. Oncogene 6, 1471-1476.
56. Mareel, M., Bracke, M., Van Roy, F., and Vakaet, L. (1993). Expression of E-cadherin in embryogenetic ingression and cancer invasion. Int. J. Dev. Biol. 37, 227-235.
57. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R.S., Zborowska, E., Kinzler, K.W., and Vogelstein, B. (1995). Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268, 1276-1277.
58. Miettinen, P.J., Ebner, R., Lopez, A.R., and Derynck, R. (1994). TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol. 127, 2021-2036.
59. Millan, F.A., Kondaiah, P., Denhez, F., and Akhurst, R.J. (1991). Embryonic expression patterns of TGFβ1, 2 and 3 suggest different functions in vivo. Development 111, 131-144.
60. Missero, C., Cajal, S.R.Y., and Dotto, G.P. (1991). Escape from transforming growth factor β control and oncogene cooperation in skin tumor development. Proc. Natl. Acad. Sci. USA 88, 9613-9617.
61. Nelson, K.G., and Slaga, T.J. (1982). Keratin modifications in epidermis, papillomas, and carcinomas during two-stage carcinogenesis in the SENCAR mouse. Cancer Res. 42, 4176-4181.
62. Nischt, R., Roop, D.R., Mehrel, T., Yuspa, S.H., Rentrop, M., Winter, H., and Schweizer, J. (1988). Aberrant expression during two-stage mouse skin carcinogenesis of a type I 47 kDa keratin, K13, normally associated with terminal differentiation of internal stratified epithelia. Mol. Carcinog. 1, 96-108.
63. Pelton, R.W., Hogan, B.L., Miller, D.A., and Moses, H.L. (1990). Differential expression of genes encoding TGFs β1, β2, and β3 during murine palate formation. Dev. Biol. 141, 456-460.
64. Pierce, D.F., Jr., Gorska, A.E., Chytil, A., Meise, K.S., Page, D.L., Coffey, R.J., Jr., and Moses, H.L. (1995). Mammary tumor suppression by transforming growth factor β1 transgene expression. Proc. Natl. Acad. Sci. USA 92, 4254-4258.
65. Potts, J.D., and Runyan, R.B. (1989). Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor β. Dev. Biol. 134, 392-401.
66. Proetzel, G., Pawlowski, S.A., Wiles, M.V., Yin, M., Boivin, G.P., Howles, P.N., Ding, J., Ferguson, M.J., and Doetschman, T. (1995). Transforming growth factor-β3 is required for secondary palate fusion. Nature Genet. 11, 409-414.
67. Roberts, A.B., and Sporn, M.B. (1990). The transforming growth factor βs. In Peptide Growth Factors and Their Receptors: Handbook of Experimental Pharmacology, M.B. Sporn and A.B. Roberts, eds. (Heidelberg, Federal Republic of Germany: Springer-Verlag), pp. 419-472.
68. Roberts, A.B., Sporn, M.B., Assoian, R.K., Smith, J.M., Roche, N.S., Wakefield, L.M., Heine, U.I., Liotta, L.A., Falanga, V., Kehrl, J.H. et al. (1986). Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83, 4167-4171.
69. Roop, D.R., Krieg, T.M., Mehrel, T., Cheng, C.K., and Yuspa, S.H. (1988). Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis. Cancer Res. 48, 3245-3252.
70. Rotello, R.J., Leiberman, R.C., Purchio, A.F., and Gerschenson, L.E. (1991). Coordinated regulation of apoptosis and cell proliferation by transforming growth factor β1 in cultured uterine epithelial cells. Proc. Natl. Acad. Sci. USA 88, 3412-3415.
71. Samuel, S.R., Hurta, R.A.R., Kondaiah, P., Khalil, N., Turley, E.A., Wright, J.A., and Greenberg, A.H. (1992). Autocrine induction and tumour protease production and invasion by a metalloproteinase-regulated TGFβ1. EMBO J. 11, 1599-1605.
72. Sellheyer, K., Bickenbach, J.R., Rothnagel, J.A., Bundman, D., Longley, M.A., Krieg, T., Roche, N.S., Roberts, A.B., and Roop, D.R. (1993). Inhibition of skin development by overexpression of transforming growth factor β1 in the epidermis of transgenic mice. Proc. Natl. Acad. Sci. USA 90, 5237-5241.
73. Sieweke, M.H., Thompson, N.L., Sporn, M.B., and Bissell, M.J. (1990). Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-β. Science 248, 1656-1660.
74. Steiner, M.S., and Barrack, E.R. (1992). Transforming growth factor-β-1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol. Endocrinol. 6, 15-25.
75. Stoler, A., Stenback, F., and Balmain, A. (1993). The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event. J. Cell Biol. 122, 1103-1117.
76. Sun, L., Wu, G., Willson, J.K.V., Zborowska, E., Yang, J., Rajkarunanayake, I., Wang, J., Gentry, L.E., Wang, X., and Brittain, M.G. (1994). Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J. Biol. Chem. 42, 26449-26455.
77. Tennenbaum, T., Yuspa, S.H., Grover, A., Castronovo, V., Sobel, M.E., Yamada, Y., and DeLuca, L.M. (1992). Extracellular matrix receptors and mouse skin carcinogenesis: altered expression linked to early markers of tumor progression. Cancer Res. 52, 2966-2976.
78. Tennenbaum, T., Weiner, A.K., Belanger, A.J., Glick, A.B., Henning, H., and Yuspa, S.H. (1993). The suprabasal expression of α6β4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis. Cancer Res. 53, 4803-4810.
79. Terzaghi-Howe, M. (1989). Changes in response to, and production of, transforming growth factor type β during neoplastic progression in cultured rat tracheal epithelial cells. Carcinogenesis 10, 973-980.
80. Toftgard, R., Yuspa, S.H., and Roop, D.R. (1985). Keratin gene expression in mouse skin tumors and in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 45, 5845-5850.
81. Torre-Amione, G., Beauchamp, R.D., Koeppen, H., Park, B.H., Schreiber, H., Moses, H.L., and Rowley, D.A. (1990). A highly immunogenic tumor transfected with a murine transforming growth factor type β-1 cDNA escapes immune surveillance. Proc. Natl. Acad. Sci. USA 87, 1486-1490.
82. Umbhauer, M., Marshall, C.J., Mason, C.S., Old, R.W., and Smith, J.C. (1995). Mesoderm induction in Xenopus caused by activation of MAP kinase. Nature 376, 58-62.
83. Valles, A.M., Boyer, B., and Thierry, J.P. (1991). Adhesion systems in embryonic epithelial-to-mesenchyme transformation and in cancer invasion and metastasis. Experimentia 59 (Suppl.), 17-34.
84. Wakefield, L.M., Smith, D.M., Masui, T., Harris, C.C., and Sporn, M.B. (1987). Distribution and modulation of the cellular receptor for transforming growth factor-β. J. Cell Biol. 105, 965-975.
85. Wakefield, L.M., Winokur, T.S., Hollands, R.S., Christopherson, K., Levinson, A.D., and Sporn, M.B. (1990). Recombinant latent transforming growth factor β1 has a longer plasma half-life in rats than transforming growth factor β1, and a different tissue distribution. J. Clin. Invest. 86, 1976-1984.
86. Wang, D., Zhou, G., Birkenmeier, T.M., Gong, J., Sun, L., and Brattain, M.G. (1995). Autocrine transforming growth factor β1 modulates the expression of integrin α5β1 in human colon carcinoma FET cells. J. Biol. Chem. 270, 14154-14159.
87. Welch, D.R., Fabra, A., and Nakajima, M. (1990). Transforming growth factor β1 stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Natl. Acad. Sci. USA 87, 7678-7682.
88. Whitman, M., and Melton, M.S. (1992). Involvement of p21 (ras) in Xenopus mesoderm induction. Nature 357, 252-254.
89. Winter, H., Schweizer, J., and Goerttler, K. (1980). Keratins as markers of malignancy in mouse epidermal tumors. Carcinogenesis 1, 391-398.
90. Wu, J.E., and Santoro, S.A. (1994). Complex patterns of expression suggest roles for the α2β1 integrin in murine development. Dev. Dyn. 199, 292-314.
91. Wu, S.P., Theodoresou, D., Kerbel, R.S., Willson, J.K., Mulder, K.M., Humphrey, L.E., and Brattain, M.G. (1992). TGF-β 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector. J. Cell Biol. 116, 187-196.
92. Wu, S.P., Sun, L., Willson, J.K.V., Humphrey, L., Kerbel, K., and Brattain, M.G. (1993). Repression of autocrine transforming growth factor β1 and β2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties. Cell Growth Differ. 4, 115-123.
93. Yuspa, S.H., Dlugosz, A.A., Cheng, C.K., Denning, M.F., Tennenbaum, T., Glick, A.B., and Weinberg, W.C. (1995). Role of oncogenes and tumor suppressor genes in multistage carcinogenesis. J. Invest. Dermatol. 103, 90S-95S.